(Q37017315)

17 August 2017

2 references

2 October 2019

17 November 2019

The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD. (English)

1 reference

chronic obstructive pulmonary disease

17 August 2017

2 references

2 October 2019

17 November 2019

1 reference

2 October 2019

2 references

2 October 2019

17 November 2019

1 reference

17 November 2019

2

Nicola A Hanania

1 reference

17 August 2017

Mario Cazzola

1

1 reference

PMC publication ID

2707808

17 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

International Journal of Chronic Obstructive Pulmonary Disease

17 August 2017

3 references

17 August 2017

2 October 2019

17 November 2019

1

1 reference

17 August 2017

4

1 reference

17 August 2017

345-354

1 reference

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Patient-centred outcomes in primary care management of COPD - what do recent clinical trial data tell us?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Addition of salmeterol to existing treatment in patients with COPD: a 12 month study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Evaluating the effectiveness of combination therapy to prevent COPD exacerbations: the value of NNT analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Corticosteroid resistance in airway disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Interventions to prevent chronic obstructive pulmonary disease exacerbations.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Treatment of stable chronic obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

COPD exacerbations: the importance of a standard definition

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

β-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Improving patient compliance with asthma therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Measuring compliance with inhaled medication in asthma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Longitudinal changes in the nature, severity and frequency of COPD exacerbations.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Combination therapy for chronic obstructive pulmonary disease: one size fits all?

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2707808

Type 1 cytokines and the pathogenesis of tuberculosis.

4 December 2018

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Respiratory failure in chronic obstructive pulmonary disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Application of Number Needed to Treat (NNT) as a Measure of Treatment Effect in Respiratory Medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Corticosteroid reversibility in COPD is related to features of asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Inhaled corticosteroids and the risk of a first exacerbation in COPD patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FCOPD.2006.1.4.345

Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18044091

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18044091

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/COPD.2006.1.4.345

1 reference

17 August 2017

1 reference

PMC publication ID

2707808

17 August 2017

PubMed publication ID

18044091

1 reference

PMC publication ID

2707808